Abstract
Over recent years significant advances in histopathology and functional imaging techniques for the diagnosis and restaging of children with neuroblastoma have led to better quantification of disease and assessment of disease response, allowing for better treatment stratification. In this review we summarise recent changes to the International Neuroblastoma Response Criteria including the use of RECIST (Response Evaluation Criteria in Solid Tumours) guidance for measurable soft-tissue disease, replacement of technetium-99 m-methylene diphosphonate (MDP) bone scans with metaiodobenzylguanidine (MIBG) scan or [F-18]2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET)/CT scanning, and a new category of minimal residual bone marrow disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Park JR, Bagatell R, Cohn SL et al (2017) Revisions to the International Neuroblastoma Response Criteria: a consensus statement from the National Cancer Institute clinical trials planning meeting. J Clin Oncol 35:2580–2587
Bagatell R, McHugh K, Naranjo A et al (2016) Assessment of primary site response in children with high-risk neuroblastoma: an international multicenter study. J Clin Oncol 34:740–746
Brodeur GM, Seeger RC, Barrett A et al (1988) International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6:1874–1881
Brodeur GM, Pritchard J, Berthold F et al (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466–1477
Monclair T, Brodeur GM, Ambros PF et al (2009) The International Neuroblastoma Risk Group (INRG) staging system: an INRG task force report. J Clin Oncol 27:298–303
Cecchetto G, Mosseri V, De Bernardi B et al (2005) Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol 23:8483–8489
Sundell IB, Hallmans G, Nilsson TK et al (1989) Plasma glucose and insulin, urinary catecholamine and cortisol responses to test breakfasts with high or low fibre content: the importance of the previous diet. Ann Nutr Metab 33:333–340
Weetman RM, Rider PS, Oei TO et al (1976) Effect of diet on urinary excretion of VMA, HVA, metanephrine, and total free catecholamine in normal preschool children. J Pediatr 88:46–50
Goo HW (2010) Whole-body MRI of neuroblastoma. Eur J Radiol 75:306–314
Brisse HJ, McCarville MB, Granata C et al (2011) Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group project. Radiology 261:243–257
Mueller WP, Coppenrath E, Pfluger T (2013) Nuclear medicine and multimodality imaging of pediatric neuroblastoma. Pediatr Radiol 43:418–427
Bar-Sever Z, Biassoni L, Shulkin B et al (2018) Guidelines on nuclear medicine imaging in neuroblastoma. Eur J Nucl Med Mol Imaging 45:2009–2024
Lewington V, Lambert B, Poetschger U et al (2017) (123)I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting method by an international panel. Eur J Nucl Med Mol Imaging 44:234–241
Yanik GA, Parisi MT, Shulkin BL et al (2013) Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group. J Nucl Med 54:541–548
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Orr, K.E., McHugh, K. The new international neuroblastoma response criteria. Pediatr Radiol 49, 1433–1440 (2019). https://doi.org/10.1007/s00247-019-04397-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-019-04397-2